SRE

Sempra

$81.88

+0.66%
Oct 12, 2026
Bobby Quantitative Model
Sempra is a diversified utility holding company that distributes natural gas and electricity to one of the largest customer bases in the United States, primarily through Southern California Gas and San Diego Gas & Electric, while also owning 80% of Oncor, a major transmission and distribution business in Texas. The company further differentiates itself through Sempra Infrastructure Partners, which owns and operates liquefied natural gas facilities in North America and energy infrastructure in Mexico, giving it a unique blend of regulated utility stability and global energy infrastructure growth. The current investor narrative is dominated by the tension between Sempra's defensive, rate-base-driven earnings model and a sharp market de-rating over the past year, as reflected in the stock's significant underperformance versus the S&P 500. Recent developments, including SoCalGas's push to retire preferred stock at a premium to simplify its capital structure, highlight management's focus on financial flexibility and balance sheet optimization amid a heavy capital expenditure cycle. Investors are debating whether the selloff has created a value opportunity in a regulated utility with visible long-term growth, or whether persistent free cash flow deficits and rising leverage justify the discounted valuation.

People also watch

AES Corporation

AES Corporation

AES

Analysis
Black Hills Corporation

Black Hills Corporation

BKH

Analysis
NorthWestern Energy Group, Inc. Common Stock

NorthWestern Energy Group, Inc. Common Stock

NWE

Analysis
NextEra Energy

NextEra Energy

NEE

Analysis
Southern Company

Southern Company

SO

Analysis

BobbyInvestment Opinion: Should I buy SRE Today?

Based on the synthesis, SRE is rated a Hold with a value bias. The analyst consensus is Buy with an average target of $99.92, implying 22.8% upside, but the market's skepticism and the stock's deep underperformance suggest caution. The core thesis is that the selloff has created a value opportunity, but execution risks and financial strain warrant a wait-and-see approach until earnings recovery is confirmed.

The supporting evidence includes a forward PE of 14.68x, which is reasonable for a utility, and a price-to-book of 1.82x, near the middle of its historical range. Revenue has been flat, with Q2 2026 revenue of $2.997 billion down 0.1% YoY, but net margin improved to 26.59% from 15.77%. Free cash flow remains deeply negative at -$5.895 billion TTM, and the dividend yield of 2.85% is supported by an 89.44% payout ratio. The implied upside to the average target is 22.8%, but the wide target range ($83-$118) reflects uncertainty.

Key risks include the persistent negative free cash flow, high leverage (debt-to-equity 1.15), and regulatory headwinds. The rating would upgrade to Buy if forward EPS estimates are met and free cash flow turns positive, or if the stock breaks above $87. It would downgrade to Sell if revenue declines further or if the dividend is cut. Relative to its history, the stock is undervalued on forward earnings but fairly valued on a P/B basis. The market is pricing in a recovery that may take time to materialize.

Sign up to view all

SRE 12-Month Price Forecast

Sempra presents a mixed picture: deep value on forward earnings but significant execution risks. The market is skeptical, as evidenced by the stock's underperformance, but analyst consensus remains bullish. The key driver will be whether the company can achieve its EPS estimate and improve cash flow. A break above $87 would signal a trend change, while a drop below $76 would be bearish. I would upgrade to bullish if free cash flow turns positive and EPS meets estimates; downgrade to bearish if the dividend is cut or regulatory setbacks occur.

Historical Price
Current Price $81.88
Average Target $92.50
High Target $118.00
Low Target $76.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Sempra's 12-month outlook, with a consensus price target around $99.03 and implied upside of +20.9% versus the current price.

Average Target

$99.03

0 analysts

Implied Upside

+20.9%

vs. current price

Analyst Count

—

covering this stock

Price Range

$83 - $118

Analyst target range

Sempra is covered by 18 analysts, with a consensus recommendation of "Buy" and a recommendation mean of 1.6 (where 1 is Strong Buy and 5 is Strong Sell). The average target price is $99.92, which implies 22.8% upside from the current price of $81.34. The consensus is clearly bullish, with the average target well above the current price, suggesting that analysts believe the recent selloff is overdone. However, the stock's persistent underperformance and negative relative strength indicate that the market is not yet pricing in this optimism, creating a potential disconnect between analyst expectations and investor sentiment.

The target price range spans from a low of $83.00 to a high of $118.00, a spread of $35.00 or 42% of the current price, which signals significant uncertainty about the company's outlook. The high target of $118.00 implies a 45% upside and likely assumes successful execution on the capital expenditure program, favorable regulatory outcomes, and a recovery in earnings that justifies multiple expansion. The low target of $83.00, just 2% above the current price, suggests a more conservative view that accounts for margin compression, higher financing costs, or delays in rate case approvals. Institutional ratings show a mix of actions: Jefferies upgraded the stock from Hold to Buy on September 1, 2026, while Mizuho downgraded from Outperform to Neutral on August 31, 2026, indicating divergent views. Morgan Stanley, Truist, JP Morgan, and Barclays have maintained Overweight or Buy ratings, suggesting that the bullish case remains intact among major firms, but the wide target spread and recent downgrade highlight the risks. The estimated EPS average of $7.17 for the forward year, if achieved, would represent a significant recovery from trailing EPS of $0.03, and the estimated revenue average of $14.64 billion implies modest growth, reinforcing the view that the investment case hinges on margin recovery and capital efficiency rather than top-line acceleration.

Drowning in data?

Find the real signal!

Bulls vs Bears: SRE Investment Factors

The bear case currently has stronger evidence due to the stock's persistent underperformance, negative free cash flow, and high leverage. However, the bull case rests on a potential earnings recovery that would make the forward valuation compelling. The single most important tension is whether Sempra can execute its capital program and achieve the $7.17 EPS estimate, which would justify a significant re-rating. If earnings disappoint, the stock could remain depressed or fall further. The market is clearly skeptical, as reflected in the 27% relative underperformance over the past year.

Bullish

  • Deep Value on Forward Earnings: The forward PE of 14.68x is well below the trailing PE of 32.11x, implying the market expects earnings to more than double to $7.17 per share. If achieved, the stock trades at just 11.3x forward earnings, a steep discount to the broader utility sector.
  • Analyst Consensus Strongly Bullish: 18 analysts rate SRE a Buy with a mean recommendation of 1.6, and the average target price of $99.92 implies 22.8% upside from $81.34. The high target of $118 suggests 45% upside if execution improves.
  • Regulated Utility Stability with Growth: Sempra's regulated rate base (SoCalGas, SDG&E, Oncor) provides predictable cash flows, while Sempra Infrastructure's LNG assets offer growth. Q2 2026 net income was $797 million, a 26.6% net margin, up from 15.8% a year ago.
  • Low Beta Defensive Profile: With a beta of 0.56, SRE is significantly less volatile than the market, making it an attractive defensive holding. The recent bounce from $76.21 to $81.34 suggests early accumulation at deep value levels.

Bearish

  • Persistent Negative Free Cash Flow: TTM free cash flow is -$5.895 billion, with Q2 2026 capex of $4.687 billion far exceeding operating cash flow of $3.117 billion. This cash burn necessitates continuous external financing, increasing financial risk.
  • High Leverage and Payout Strain: Debt-to-equity is 1.15 and total debt-to-capitalization is 52.85%. The dividend payout ratio of 89.44% leaves little cushion, and with ROE of only 5.81%, the company's returns are below its cost of capital.
  • Earnings Volatility and Weak Trailing EPS: Trailing EPS is just $0.03, reflecting one-time items and regulatory timing. Q3 2025 net income was only $95 million (2.98% net margin), highlighting the potential for severe earnings swings.
  • Significant Underperformance vs. Market: SRE is down 11.24% over the past year while the S&P 500 gained 16%, a relative strength of -27.24%. The stock trades at just 20.6% of its 52-week range, indicating sustained selling pressure.

SRE Technical Analysis

Sempra is in a sustained downtrend, with the stock down 11.24% over the past year and 17.69% over six months, a stark contrast to the S&P 500's 16.00% gain over the same period. At a current price of $81.34, the stock is trading at just 20.6% of its 52-week range (low of $76.21, high of $101.04), sitting much closer to its annual low than its high. This positioning signals persistent selling pressure and a lack of near-term momentum, though it also places the stock in territory where value-oriented investors may begin to look for stabilization. The relative strength versus the S&P 500 is deeply negative across all timeframes, with a 1-year relative strength of -27.24%, confirming that capital has been rotating out of this utility name.

Short-term momentum remains weak but shows tentative signs of stabilization: the stock is down 4.32% over the past month, though it has rebounded 4.1% from its recent low of $78.05 on October 1 to $81.34 on October 9. The 3-month change of -13.65% and 6-month change of -17.69% indicate that the selling pressure has been persistent rather than a sudden shock, with the stock making a series of lower highs and lower lows from April through September. The 1-month relative strength of -6.44% versus the S&P 500's +2.12% shows that even during a broad market rally, Sempra has lagged significantly, suggesting company-specific or sector-specific headwinds. The recent bounce off the $76-78 area could signal early accumulation, but volume of 3.37 million shares is unremarkable, and the stock would need to break above $85-87 to confirm a trend reversal.

Key technical support sits at the 52-week low of $76.21, with the recent September 28 close of $76.89 marking a successful retest of that level. Resistance is defined by the 52-week high of $101.04, though intermediate resistance likely exists around $85-87, where the stock consolidated in August before breaking down. A breakdown below $76.21 would signal a continuation of the downtrend and likely trigger further selling, while a breakout above $87 would be the first meaningful sign of a trend change. With a beta of just 0.56, Sempra is significantly less volatile than the broader market, meaning its 22.92% maximum drawdown is notable for a low-beta utility and reflects the severity of the de-rating. For risk management, the low beta suggests the stock may not participate fully in market rallies, but it also implies that the recent decline is driven by fundamental concerns rather than broad market volatility.

Beta

0.56

0.56x market volatility

Max Drawdown

-22.9%

Largest decline past year

52-Week Range

$76-$101

Price range past year

Annual Return

-9.2%

Cumulative gain past year

PeriodSRE ReturnS&P 500
1m-1.8%+1.8%
3m-12.3%+3.5%
6m-14.2%+11.2%
1y-9.2%+19.1%
ytd-8.7%+14.1%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

SRE Fundamental Analysis

Sempra's revenue trajectory has been essentially flat, with Q2 2026 revenue of $2.997 billion representing a -0.1% year-over-year decline from $3.000 billion in Q2 2025. The multi-quarter trend shows revenue oscillating between $2.68 billion and $3.80 billion, with no clear growth direction; Q1 2026 revenue of $3.655 billion was down from $3.798 billion in Q1 2025, while Q4 2025 revenue of $3.766 billion was roughly in line with Q4 2024's $3.753 billion. Segment data reveals that gas revenues of $1.509 billion and electric revenues of $1.290 billion are the primary contributors, with other revenues adding $263 million, but the lack of meaningful top-line growth suggests the company is relying on rate base growth and cost management rather than volume or pricing expansion. For a utility, this is not unusual, but it places greater emphasis on regulatory outcomes and capital deployment efficiency to drive earnings growth.

Profitability remains solid but uneven, with Q2 2026 net income of $797 million translating to a net margin of 26.59%, up from 15.77% in Q2 2025, though the prior-year quarter was depressed by higher costs. Gross margin in Q2 2026 was 54.65%, a significant improvement from 24.97% in Q2 2025, though this volatility reflects the impact of regulatory adjustments and cost pass-through mechanisms rather than a structural margin expansion. The trailing twelve-month net margin stands at 13.40%, and the operating margin is 23.72%, both of which are respectable for a diversified utility but below the premium margins of pure-play regulated electric utilities. The Q3 2025 quarter was particularly weak, with net income of just $95 million and a net margin of 2.98%, highlighting the earnings volatility that can arise from one-time items and regulatory timing.

Sempra's balance sheet carries meaningful leverage, with a debt-to-equity ratio of 1.148 and total debt-to-capitalization of 52.85%, which is elevated but not atypical for a capital-intensive utility. The company generated $3.117 billion in operating cash flow in Q2 2026, but capital expenditures of $4.687 billion resulted in negative free cash flow of -$1.570 billion for the quarter, and TTM free cash flow is deeply negative at -$5.895 billion. This persistent cash burn means Sempra depends on external financing to fund its growth capex, as evidenced by $2.194 billion in net cash from financing activities in Q2 2026, including $3.548 billion in debt repayment and $826 million in dividends paid. The current ratio of 1.59 provides adequate short-term liquidity, but the dividend payout ratio of 89.44% and dividend yield of 2.85% leave little room for error if earnings disappoint. ROE of 5.81% and ROA of 1.96% are low relative to the cost of capital, suggesting that the company's growth investments have yet to translate into attractive returns.

Quarterly Revenue

$3.0B

2026-06

Revenue YoY Growth

-0.1%

YoY Comparison

Gross Margin

54.6%

Latest Quarter

Free Cash Flow

$-5.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Gas
Electric
Utilities regulatory revenues
Other revenues

Open an Account, get $2 TSLA now!

Valuation Analysis: Is SRE Overvalued?

Because Sempra is profitable with positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 32.11x, while the forward PE is 14.68x, implying that the market expects earnings to more than double over the next year. This enormous gap between trailing and forward multiples reflects the depressed trailing earnings base, which has been weighed down by one-time items and regulatory timing, and suggests that analysts are pricing in a significant earnings recovery. The forward PE of 14.68x is reasonable for a regulated utility, but the market is clearly skeptical given the stock's 11.24% decline over the past year.

Compared to the broader utilities sector, Sempra's valuation presents a mixed picture. The price-to-book ratio of 1.82x is modest for a utility with a large regulated asset base, and the price-to-sales ratio of 4.20x is elevated relative to historical norms. The EV/EBITDA of 13.67x is above the typical utility range of 10-12x, suggesting the market is ascribing value to the unregulated Sempra Infrastructure business. However, the PEG ratio of -0.84 is negative due to the earnings decline, making it uninformative. Without explicit industry average data, we note that Sempra's forward PE of 14.68x is broadly in line with large-cap utility peers, but its trailing PE of 32.11x represents a significant premium that is unlikely to be sustained if earnings do not recover as expected.

Historically, Sempra's PE ratio has ranged from a low of 12.28x in Q1 2023 to a high of 187.46x in Q3 2025, with the current trailing PE of 32.11x sitting in the upper half of that range. The price-to-book ratio of 1.82x is near the middle of its historical band, which has ranged from 1.47x to 2.04x over the past three years. The current valuation suggests that the market is pricing in a recovery in earnings, but the stock's depressed price and negative relative strength indicate that investors are not yet convinced. If forward earnings estimates of $7.17 per share are achieved, the stock would be trading at just 11.3x forward earnings, which would represent a deep value opportunity; however, the risk is that continued negative free cash flow and high leverage could lead to further multiple compression.

PE

32.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 12x~28x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

13.7x

Enterprise Value Multiple

Investment Risk Disclosure

Sempra faces significant financial and operational risks. The company's TTM free cash flow is deeply negative at -$5.895 billion, driven by a heavy capital expenditure program that far exceeds operating cash flow. With a debt-to-equity ratio of 1.15 and total debt-to-capitalization of 52.85%, leverage is elevated, and the dividend payout ratio of 89.44% leaves little room for error. ROE of 5.81% and ROA of 1.96% are low relative to the cost of capital, indicating that growth investments have yet to generate attractive returns. Additionally, earnings volatility is high, as seen in Q3 2025 when net income plummeted to $95 million (2.98% net margin) from $649 million a year earlier.

Market and competitive risks are also prominent. The stock's beta of 0.56 suggests lower volatility, but its 22.92% maximum drawdown over the past year is severe for a utility, reflecting company-specific concerns. Valuation compression risk is real: the trailing PE of 32.11x is well above the historical median, and if earnings fail to recover, the multiple could contract further. The EV/EBITDA of 13.67x is above the typical utility range of 10-12x, pricing in growth from Sempra Infrastructure. Regulatory risks in California and Texas, including rate case outcomes and wildfire liability, could pressure earnings. Recent news of SoCalGas retiring preferred stock at a premium may strain liquidity in the short term.

In a worst-case scenario, a combination of regulatory setbacks, delays in LNG projects, and continued negative free cash flow could trigger a downgrade and dividend cut. The stock could retest its 52-week low of $76.21, representing a 6.3% decline from the current price of $81.34. If the bear case fully materializes, the analyst low target of $83.00 offers little downside protection, but a more severe scenario could see the stock fall to the $70s, a 12-15% drop. The maximum drawdown of 22.92% from the 52-week high of $101.04 implies a potential low of $77.90, close to the 52-week low. Investors could lose 6-15% from current levels in an adverse scenario.

FAQ

The biggest risk is financial: TTM free cash flow is -$5.895 billion, and debt-to-equity is 1.15, which could strain the balance sheet if earnings disappoint. Regulatory risk is also high, as adverse rate case outcomes in California or Texas could pressure margins. Competitive and market risks include the stock's underperformance (-27.24% relative strength vs. S&P 500) and potential multiple compression if growth slows. Finally, company-specific risks include execution on LNG projects and the success of the preferred stock retirement. A dividend cut would be a severe negative catalyst.

The 12-month forecast has three scenarios: bull case (25% probability) targets $100-$118 if earnings recover and regulatory outcomes are favorable; base case (55% probability) targets $85-$100 with gradual recovery; bear case (20% probability) targets $76-$83 if execution falters. The base case is most likely, assuming EPS meets the $7.17 estimate and free cash flow remains negative but narrows. The key assumption is that the company can achieve its earnings targets without a dividend cut.

SRE appears undervalued on forward earnings, with a forward PE of 14.68x compared to a trailing PE of 32.11x. The price-to-book ratio of 1.82x is near the middle of its historical range, suggesting fair value on assets. However, the EV/EBITDA of 13.67x is above the typical utility range of 10-12x, indicating a premium for growth. The market is pricing in a significant earnings recovery, but skepticism remains due to negative free cash flow. If the company meets its $7.17 EPS estimate, the stock could be deeply undervalued.

SRE may be a good buy for value-oriented investors willing to wait for an earnings recovery. The stock trades at a forward PE of 14.68x, with analyst targets implying 22.8% upside to $99.92. However, the company faces significant risks, including negative free cash flow of -$5.895 billion and a high dividend payout ratio of 89.44%. The stock is down 11.24% over the past year, and a break below $76.21 could lead to further losses. It is best suited for patient investors with a long-term horizon who believe in the regulated utility growth story.

SRE is more suitable for long-term investment due to its regulated utility nature, low beta of 0.56, and 2.85% dividend yield. The stock's earnings visibility is moderate, with a forward PE of 14.68x and analyst estimates for $7.17 EPS. Short-term trading is risky given the downtrend and negative momentum. A minimum holding period of 2-3 years is recommended to allow for earnings recovery and regulatory outcomes. The low beta makes it a defensive holding, but the negative free cash flow adds risk.